Results 161 to 170 of about 1,729 (232)

Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands. [PDF]

open access: yesEur J Health Econ
van der Schans S   +7 more
europepmc   +1 more source

MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY

open access: yes, 2016
Theodosiou, A   +11 more
openaire   +1 more source

Diagnostic Journey of Korean Patients with Spinal Muscular Atrophy. [PDF]

open access: yesYonsei Med J
Kim SH   +6 more
europepmc   +1 more source

Reduced white matter integrity and disrupted brain network in children with type 2 and 3 spinal muscular atrophy. [PDF]

open access: yesJ Neurodev Disord
Nie H   +11 more
europepmc   +1 more source

Administration practices of and adherence to nusinersen in children with spinal muscular atrophy: a multicenter disease registry study in China. [PDF]

open access: yesBMC Pediatr
Peng J   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy